YOLFTbeta
TelyRx Holdings Inc.

TelyRx Holdings Inc.

TELY · TO · Healthcare / Pharmaceutical Retailers

2.00CAD-0.07 (-3.38%)

Price History

Full chart

Market Stats

Previous Close2.07
Open2.05
Day Range2.00 – 2.05
52-Week Range2.00 – 4.25
Volume2.40K
Market Cap69.14M
P/E (TTM)0.00
Forward P/E9.04
EPS-0.71
Dividend Yield0.00%
50-Day Avg2.50
200-Day Avg2.67

About

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMs. Vanessa Slowey
  • Headquarters24761 US Hwy 19N, Clearwater, FL, United States, 33763, Canada
  • Websitehttps://TelyRx.com

Leadership

  • Ms. Vanessa SloweyPresident, CEO & Director · b. 1969
  • Mr. John Eric CascioChief Financial Officer
  • Mr. Adam GardnerChief Operating Officer
  • Mr. John EusticeSecretary & General Counsel
  • Mr. Peter LloydChief Revenue Officer
  • Mr. Rafael JoseChief Digital Officer

Financials

Income Statement

Currency: CAD2023-12-312024-12-312025-12-31
Total Revenue27.00K9.53M42.92M
Growth (%)-+35207.41%+350.27%
Cost of Revenue25.00K6.02M19.61M
Gross Profit2.00K3.51M23.32M
Gross Margin7.41%36.84%54.32%
Operating Expense748.00K7.44M23.76M
Operating Income-746.00K-3.93M-438.10K
Operating Margin-2762.96%-41.19%-1.02%
EBITDA-713.00K-3.62M-3.96M
EBITDA Margin-2640.74%-37.98%-9.24%
Net Income-4.39M-13.48M-423.32K
Net Income Margin-16274.07%-141.44%-0.99%
R&D073.00K-
R&D as % of Total Revenue0.00%0.77%-
Interest Expense892.00K931.00K661.00K
Interest Expense % of Total Revenue3303.70%9.77%1.54%

Balance Sheet

Currency: CAD2023-12-312024-12-312025-12-31
Total Assets11.90M7.95M1.51M
Total Liabilities13.54M10.99M64.40K
Total Equity-1.64M-3.05M1.45M
Cash231.00K3.31M1.51M
Net Debt5.33M3.90M6.18M

Cash Flow

Currency: CAD2023-12-312024-12-312025-12-31
Operating Cash Flow-2.47M-2.86M-109.14K
Financing Cash Flow348.00K7.22M1.62M
Capital Expenditure359.00K739.00K1.44M
Free Cash Flow-2.83M-3.60M-2.21M
FCF to OCF114.54%125.82%2026.75%

Earnings

Report DateMay 12, 2026Aug 10, 2026
EPS Estimate-0.03-0.06
EPS Actual-0.29-0.12
Surprise-866.67%-100.00%
TimingAfter-hoursPre-market

Key Statistics & Ratios

Market Cap69.14M
Enterprise Value48.33M
Trailing P/E0.00
Forward P/E9.04
Price / Sales1.01
Price / Book3.91
EPS-0.71
Book Value0.3137
Revenue (TTM)68.72M
Gross Profit (TTM)38.46M
EBITDA-12.21M
Profit Margin-19.36%
Operating Margin-24.05%
Return on Equity0.00%
Return on Assets-33.41%
Shares Outstanding26.37M
Shares Float11.81M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%